Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-01-26Clinical Trial Update: Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT [Phase 2]
A Phase II trial evaluating busulfan and fludarabine as preparative conditioning therapy in adults with hematopoietic disorders undergoing m…
-
CLINICAL_TRIALS trial_result · 2009-01-23Clinical Trial Update: Arsenic Trioxide and Thalidomide in the Treatment of Refractory Multiple Myeloma [Phase 2]
A Phase 2 study evaluating the combination of arsenic trioxide and thalidomide in patients with refractory multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: A Trial of Skeletal Targeted Radiotherapy Using Holmium-166-DOTMP in Patients With Multiple Myeloma [Phase 1, Phase 2]
The clinical trial update reports the termination of a Phase 1/Phase 2 study evaluating Holmium-166-DOTMP for skeletal-targeted radiotherapy…
-
CLINICAL_TRIALS research · 2009-01-13Clinical Trial Update: Study of Fluphenazine in Relapsed or Relapsed-and-Refractory Multiple Myeloma [Phase 1]
This trial entry documents a Phase 1 study evaluating fluphenazine in patients with relapsed or relapsed-and-refractory multiple myeloma. Th…
-
CLINICAL_TRIALS trial_result · 2009-01-07Clinical Trial Update: Behavioral Intervention For BMT/SCT Survivors
A completed clinical trial evaluated a behavioral intervention for bone marrow transplant and stem cell transplant survivors. The study incl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-12-15FDA Approved: MOZOBIL — Original Application (Sanofi-Aventis U.S. LLC)
FDA approved Mozobil (plerixafor) under an Original Application (NDA022311) to mobilize hematopoietic stem cells in combination with G-CSF f…
-
CLINICAL_TRIALS research · 2008-12-09Clinical Trial Update: Autologous Stem Cell Transplant (ASCT) With Intravenous Busulfan and Melphalan as Conditioning Regimen [Phase 2]
Phase 2 clinical trial evaluating autologous stem cell transplantation using intravenous busulfan and melphalan as conditioning for multiple…
-
CLINICAL_TRIALS trial_result · 2008-11-27Clinical Trial Update: A Study of Thalidomide Plus Dexamethasone (Thal-Dex) Versus DOXIL plusThalidomide Plus Dexamethasone (DOXIL -Thal-Dex) in Patients With Newly Diagnosed Multiple Myeloma [Phase 3]
Phase 3 trial comparing Thalidomide plus Dexamethasone (Thal-Dex) to DOXIL plus Thal-Dex in newly diagnosed multiple myeloma. The study comp…
-
CLINICAL_TRIALS trial_result · 2008-11-27Clinical Trial Update: Pethema Multiple Myeloma 2000 [Phase 3]
Phase 3 clinical trial update for Pethema Multiple Myeloma 2000; the study has completed.
-
CLINICAL_TRIALS withdrawal · 2008-10-28Clinical Trial Update: A Study of ATN-224 and Bortezomib in Patients With Multiple Myeloma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating ATN-224 in combination with Bortezomib for multiple myeloma has been terminated.
-
FDA approval · 2008-06-20FDA Approved: VELCADE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Velcade (bortezomib) submitted by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2008-06-20Clinical Trial Update: Tandem Autologous- Nonmyeloablative Allogeneic Transplant for Newly Diagnosed Multiple Myeloma (Trapianto Tandem Autologo-Allogenico Non Mieloablativo Nel Mieloma Alla Diagnosi) [Phase 2]
This entry reports on a Phase 2 clinical trial evaluating tandem autologous and nonmyeloablative allogeneic stem cell transplantation for ne…
-
CLINICAL_TRIALS trial_result · 2008-06-20Clinical Trial Update: Hematopoietic Stem Cell Transplantation in Myeloma [Phase 2, Phase 3]
This clinical trial update discusses a Phase 2/Phase 3 study of hematopoietic stem cell transplantation for multiple myeloma, with the curre…
-
CLINICAL_TRIALS research · 2008-06-09Clinical Trial Update: Comparison Between FDG-PET and MRI for the Assessment of Response to Intensive Chemotherapy in Multiple Myeloma Patients. [NA]
This clinical trial update compares FDG-PET and MRI for assessing response to intensive chemotherapy in patients with multiple myeloma. The …
-
CLINICAL_TRIALS trial_result · 2008-05-20Clinical Trial Update: Safety Study of IPI-504 in Patients With Relapsed and Relapsed Refractory Multiple Myeloma [Phase 1]
A Phase 1 safety study of the HSP90 inhibitor IPI-504 in patients with relapsed and relapsed-refractory multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2008-05-06Clinical Trial Update: VTD Followed By MPT Maintenance As a First Line Treatment For The Patients With MM Who Are Non-Transplant Candidates [Phase 2]
This clinical trial update reports on a Phase 2 study of first-line therapy for non-transplant-eligible multiple myeloma patients using VTD …
-
CLINICAL_TRIALS research · 2008-05-06Clinical Trial Update: TCD Followed by autoSCT for Newly Diagnosed MM Patients [Phase 2]
Phase 2 clinical trial by the Korean Multiple Myeloma Working Party evaluating TCD followed by autologous stem cell transplantation in newly…
-
CLINICAL_TRIALS other · 2008-03-26Clinical Trial Update: Comparison of Melphalan-Prednisone (MP) to MP Plus Thalidomide in the Treatment of Newly Diagnosed Very Elderly Patients (> 75 Years) With Multiple Myeloma [Phase 3]
A Phase 3 trial comparing Melphalan-Prednisone versus Melphalan-Prednisone plus Thalidomide in newly diagnosed patients over 75 with multipl…
-
CLINICAL_TRIALS trial_result · 2008-03-12Clinical Trial Update: Maintenance Therapy After Thalidomide-Dexamethasone(ThaDD) for Multiple Myeloma(MM) [Phase 3]
Phase 3 clinical trial update on maintenance therapy with Thalidomide-Dexamethasone after ThaDD in multiple myeloma; the study status is com…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Comparing Treatments for Multiple Myeloma [Phase 2]
The document reports the completion of a Phase 2 trial comparing treatments for multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2008-02-11Clinical Trial Update: Evaluation of VELCADE Given as Retreatment to Multiple Myeloma Patients for Efficacy, Safety and Tolerability [Phase 4]
Phase 4 trial evaluating retreatment with Velcade (bortezomib) in multiple myeloma patients to assess efficacy, safety, and tolerability.
-
CLINICAL_TRIALS trial_result · 2008-02-08Clinical Trial Update: Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor [Phase 2]
Phase 2 clinical trial evaluating tacrolimus and mycophenolate mofetil as post-grafting immunosuppression after conditioning with Flu TBI in…
-
CLINICAL_TRIALS trial_result · 2007-12-24Clinical Trial Update: Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma [Phase 1, Phase 2]
This update reports the completion of a Phase 1/2 clinical trial evaluating a vaccination strategy in the peripheral stem cell transplant se…
-
CLINICAL_TRIALS trial_result · 2007-12-21Clinical Trial Update: Safety and Efficacy of Atiprimod for Patients With Refractory Multiple Myeloma [Phase 1, Phase 2]
This document reports on a phase 1/2 clinical trial evaluating the safety and efficacy of Atiprimod in patients with refractory multiple mye…
-
CLINICAL_TRIALS trial_result · 2007-12-21Clinical Trial Update: Protein Tyrosine Kinases (PTK) in Multiple Myeloma [Phase 2]
A Phase 2 clinical trial updating the use of protein tyrosine kinase inhibitors in multiple myeloma has completed enrollment and status as r…